Basiliximab (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Basiliximab" in English language version.

refsWebsite

Global rank English rank

1^st place

4^th place

447^th place

338^th place

2^nd place

11^th place

8^th place

68^th place

117^th place

621^st place

380^th place

doi.org

Hardinger KL, Brennan DC, Klein CL (July 2013). "Selection of induction therapy in kidney transplantation". Transplant International. 26 (7): 662–72. doi:10.1111/tri.12043. PMID 23279211. S2CID 3296555.
Waldmann TA (March 2003). "Immunotherapy: past, present and future". Nature Medicine. 9 (3): 269–77. doi:10.1038/nm0303-269. PMID 12612576. S2CID 9745527. Archived from the original on 13 April 2021. Retrieved 5 June 2020.

"Simulect EPAR". European Medicines Agency. 31 October 2009. Archived from the original on 11 January 2022. Retrieved 27 February 2023. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.

"Basiliximab Product Approval Information - Licensing Action". U.S. Food and Drug Administration (FDA). 20 February 2009. Archived from the original on 13 January 2017. Retrieved 27 February 2023.
"Basiliximab label" (PDF). Food and Drug Administration. Archived from the original (PDF) on 22 February 2017. Retrieved 16 December 2019.

Hardinger KL, Brennan DC, Klein CL (July 2013). "Selection of induction therapy in kidney transplantation". Transplant International. 26 (7): 662–72. doi:10.1111/tri.12043. PMID 23279211. S2CID 3296555.
Waldmann TA (March 2003). "Immunotherapy: past, present and future". Nature Medicine. 9 (3): 269–77. doi:10.1038/nm0303-269. PMID 12612576. S2CID 9745527. Archived from the original on 13 April 2021. Retrieved 5 June 2020.

"Simulect- basiliximab injection, powder, for solution". DailyMed. 6 October 2022. Archived from the original on 6 October 2022. Retrieved 27 February 2023.

MedlinePlus. Last Revised - 15 June 2012 Basiliximab Injection Archived 5 July 2016 at the Wayback Machine

Hardinger KL, Brennan DC, Klein CL (July 2013). "Selection of induction therapy in kidney transplantation". Transplant International. 26 (7): 662–72. doi:10.1111/tri.12043. PMID 23279211. S2CID 3296555.
Waldmann TA (March 2003). "Immunotherapy: past, present and future". Nature Medicine. 9 (3): 269–77. doi:10.1038/nm0303-269. PMID 12612576. S2CID 9745527. Archived from the original on 13 April 2021. Retrieved 5 June 2020.

"Simulect- basiliximab injection, powder, for solution". DailyMed. 6 October 2022. Archived from the original on 6 October 2022. Retrieved 27 February 2023.
"Simulect EPAR". European Medicines Agency. 31 October 2009. Archived from the original on 11 January 2022. Retrieved 27 February 2023. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
"Basiliximab Product Approval Information - Licensing Action". U.S. Food and Drug Administration (FDA). 20 February 2009. Archived from the original on 13 January 2017. Retrieved 27 February 2023.
MedlinePlus. Last Revised - 15 June 2012 Basiliximab Injection Archived 5 July 2016 at the Wayback Machine
"Basiliximab label" (PDF). Food and Drug Administration. Archived from the original (PDF) on 22 February 2017. Retrieved 16 December 2019.
Waldmann TA (March 2003). "Immunotherapy: past, present and future". Nature Medicine. 9 (3): 269–77. doi:10.1038/nm0303-269. PMID 12612576. S2CID 9745527. Archived from the original on 13 April 2021. Retrieved 5 June 2020.

Waldmann TA (March 2003). "Immunotherapy: past, present and future". Nature Medicine. 9 (3): 269–77. doi:10.1038/nm0303-269. PMID 12612576. S2CID 9745527. Archived from the original on 13 April 2021. Retrieved 5 June 2020.